Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Autobahn Therapeutics
3137
Autobahn Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Suggest edits
Raised
$76M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
GoFundMe
Dan
Industry
Edge
Illumina
San Diego Comic-Con
Bandsintown
ESET
Companies in the same industry
Prosensa
Circle Pharma
Insulete Inc.
Nexell Therapeutics, Inc.
Cyteir
Sunshine Heart, Inc.
Fibrocor Therapeutics
NorthSea Therapeutics
Imara, Inc.
Stemirna Therapeutics
Overview
Funding
1
Add info
Latest funding
$76,000,000
Venture capital (Series B) - 2020
ARCH Venture Partners
Invus
Biotechnology Value Fund
+7
Team Size
1–10
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
$76,000,000
Venture capital (Series B)
Pulse 2.0
Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders
FinSMEs
Autobahn Therapeutics Raises $76M in Series B Financing
